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Influence of Metabolism in Skin on Dosimetry
afterTopical Exposure
Robert L. Bronaugh, Steven W. Collier, Sara E. Macpherson, and
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Metabolism of chemicals occurs in skin and therefore should be taken into account when one determines topical exposure dose. Skin metabolism
is difficult to measure in vivo because biological specimens may also contain metabolites from other tissues. Metabolism in skin during percuta-
neous absorption can be studied with viable skin in flow-through diffusion cells. Several compounds metabolized by microsomal enzymes in skin
(benzo[alpyrene and 7-ethoxycoumarin) penetrated human and hairless guinea pig skin predominantly unmetabolized. However, compounds con-
taining a primary amino group (p-aminobenzoic acid, benzocaine, and azo color reduction products) were substrates for acetyltransferase activity in
skin and were substantially metabolized during absorption. A physiologically based pharmacokinetic model has been developed with an input equa-
tion, allowing modeling after topical exposure. Plasma concentrations in the hairless guinea pig were accurately predicted for the model compound,
benzoic acid, from in vitroabsorption, metabolism, and other pharmacokinetic parameters. - Environ Health Perspect 102(Suppl 1 1):71-74 (1994)
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Introduction
The skin can serve as an important portal
of entry ofchemicals into the body. When
systemic effects of a chemical are estimated
after topical exposure, metabolism in skin
must also be considered. Numerous studies
have reported substantial activity of meta-
bolic enzymes. These enzymes probably
have an important role in the activation or
elimination ofchemicals absorbed into the
body. Most enzymes found in other tissues
are present in skin. Frequently the activity
ofthese enzymes is less than the activity of
the corresponding enzymes in the liver.
Only recently have investigators recog-
nized the importance of skin's metabolic
activity during percutaneous absorption.
The lack of data is due to the difficulty in
measuring skin metabolism in vivo. When
body fluids are sampled, the contribution
ofskin cannot be separated accurately from
metabolism in the liver and other organs.
The advent of in vitro techniques for mea-
suring absorption and metabolism has
enabled investigators to more accurately
assess the importance ofskin metabolism.
The influence of skin metabolism is
determined in part by the area of skin
exposure. Skin is the largest organ of the
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body, with a surface area of 1.8 m2 and a
total weight estimated at 2.6 kg (1).
Therefore, full body exposure could result
in substantial metabolism during absorp-
tion, whereas application ofthe same dose
of chemical to a small area of skin might
saturate the enzymes, resulting in much less
metabolism.
We have developed methods for mea-
suring skin absorption and metabolism
with an in vitro flow-through diffusion cell
system. Using these procedures, we are
investigating the effects ofskin metabolism
during percutaneous absorption. Results of
some of these initial investigations indicate
the extent to which skin metabolism can
affect topical absorption. A physiologically
based pharmacokinetic (PBPK) model has
been developed to predict blood and tissue
levels after percutaneous absorption of
chemicals.
Historical Perspectives
SkinMetabolism ofPolycydlic
AromaticHydrocarbons
Many of the published studies on skin
metabolism have dealt with the dermal
toxicology of the polycyclic aromatic
hydrocarbons (PAHs). These chemicals,
which are found frequently in our environ-
ment, are potentially toxic to skin and
other organs. The effects ofthese chemicals
are relatively easy to study because they
cause skin tumors that can be seen on test
animals. Because metabolic activation of
these compounds is required to produce
toxic effects, researchers have focused
attention on skin metabolism in toxicologi-
cal studies.
Aryl hydrocarbon hydroxylase (AHH)
is an important enzyme in the metabolism
of PAHs. Its activity has been measured in
the skin, liver, lung, and other tissues (2).
The activity in skin exists primarily in the
relatively thin, but metabolically active,
epidermal layer (Table 1). AHH activity in
liver is more than 10 times that of skin,
regardless of whether the activity is
expressed as milligrams of tissue protein,
grams of tissue, or activity in the whole
organ. AHH activity in lung is similar to
that found in skin. Induction of enzyme
activity by Aroclor occurs extensively in
liver, skin, and lung.
The activities ofAHH and other major
enzymes involved in PAH metabolism in
skin were compared with those found in
rat liver (Table 2) (3). The specific activi-
ties ofall five enzymes that were compared
were higher in the liver, ranging from 4-
fold higher activity for NADPH-
cytochrome c-reductase to 185-fold higher
activity for 7-ethoxycoumarin deethylase.
Not only microsomal enzymes but also the
soluble enzymes (epoxide hydratase and
glutathione transferase) had lower activity
in the skin.
We compared the activities of glu-
tathione S-epoxide transferase in the liver,
skin, and lung, using data from a series of
publications by Mukhtar and Bresnick
(3-5) (Table 3). Using mouse data, we
found the liver is more than twice as active
as the lung and more than 10 times as
active as skin in metabolizing styrene oxide.
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Table 1. Aryl hydrocarbon hydroxylase activity in neonatal rat skin and its comparison with othertissue activities.
Control Arochlor
Tissue pmoles/min/mg protein pmoles/min/g tissue pmoles/min/organ pmoles/min/mg protein
Whole skin 0.7 18 12 11
Epidermis 0.6 13 4 12
Dermis 0.3 9 8 5
Liver 9.9 1262 676 39
Lung 0.8 19 4 7
Kidney 1.2 62 4 28
Carcass 0.3 11 40 1
Data represent the mean of three experiments and are expressed in terms of 3-hydroxide benzo[a]pyrene from
benzo[a]pyrene. Modified from Mukhtar and Bickers (2).
Table 2. Effect oftopical application ofAroclor on rat skin and liver enzymes.
Skin Liver
Enzyme Control Aroclor Control Aroclor
Aryl hydrocarbon hydroxylase 1.1 ± 0.1 14.1 ± 1.3 43.1 ± 2.5 363 ± 9.8
7-Ethoxycoumarin deethylase 0.4 ± 0.1 8.1 ± 1.8 73.8 ± 8.4 224 ± 12.6
NADPH-cytochrome c-reductase 5.8 ± 0.6 6.9 ± 0.8 23.6 ± 1.2 29.4 ± 29.4
Epoxide hydratase 0.2 ± 0.03 0.2 ± 0.04 2.6 ± 0.3 5.0 ± 0.5
Glutathione S-transferase 3.2 ± 0.2 3.1 ± 0.3 23.4 ± 1.2 36.8 ± 2.6
Data are the mean ± SD for four animals. Specific activities (and substrates) were as follows: aryl hydrocarbon
hydroxylase (benzo[a]pyrene) and ethoxycoumarin deethylase (ethoxycoumarin) activity was in pmole/min/mg of
protein; cytochrome c-reductase (cytochrome c), epoxide hydratase (styrene oxide) and glutathione transferase
(styrene oxide) were given as nmole/min/mg of protein. Modified from Mukhtar and Bickers (2).
Rat and mouse liver were equally active in
this assay. Glutathione S-epoxide trans-
ferase activity in human skin was less than
halfthat found in mouse skin.
Skin Metabolism of Steroids
The metabolism of steroids in skin has
been extensively studied. In skin, the
endogenous steroids testosterone and estra-
diol have pharmacological actions on hair
growth and the rates of epidermal cell
turnover. Anti-inflammatory steroids are
probably the most widely used class of
drugs for dermatological problems.
Researchers are interested in how these
drugs are activated, deactivated, and deliv-
ered across biological membranes (in the
form ofprodrugs) during metabolism.
In vitro studies with skin homogenates
demonstrated that testosterone is converted
to the 5a-hydroxy metabolite exclusively in
Table 3. Comparison of glutathione S-epoxide trans-
ferase activity in human and animal tissue.
Tissue
Donor Skin Liver Lung
Human 3.2 ± 0.4 ND ND
C57B1/6 mouse 7.7 83.8 ± 6.0 31.7 ± 1.3
Sprague-Dawley rat ND 86.4 ± 2.6 ND
ND, not determined. Values are the mean ± SE (when
available) of three to eight determinations. Specific
activity was determined with styrene oxide as the sub-
strate and is expressed as nmole/5 min/mg protein.
Prepared from three papers by Mukhtar and Bresnick
(3-5).
skin, whereas in the liver this reaction
results in the formation ofboth the a and
3 isomers (6). The importance ofthe skin
enzymes in the metabolism of testosterone
was further illustrated in the clinical studies
ofMauvais-Jarvis et al. (7). Labeled testos-
terone was administered to four human
volunteers by two different routes simulta-
neously: The 3H isomer was applied topi-
cally and the 14C isomer was administered
intravenously (iv). The 5a and 5,B metabo-
lites oftestosterone were determined in the
urine and expressed as the 5ao/5p ratio of
androstanediols (primary metabolites) and
17-ketosteroids (secondary metabolites)
(Table 4). The androstanediol data show
that the tritiated metabolites from percuta-
neous absorption resulted in a 3-fold
greater ratio of5a/5p metabolites. These
data confirm the earlier in vitro findings of
a preference in skin for 5a metabolism of
testosterone. Also, metabolism in skin dur-
ing percutaneous absorption is sufficient to
affect the pattern ofsystemic testosterone
metabolites; hence, the different ratios of
testosterone metabolites after iv and topical
administration.
SkinAbsorption and
MetabolismMethods
Skin metabolism can be studied in combi-
nation with skin absorption measurements
by using in vitro flow-through diffusion
cells (8) with a physiologic buffer as the
receptor fluid (9). Viability ofthe skin can
be maintained in diffusion cells for at least
24 hr, as assessed by maintenance ofglucose
utilization and metabolic activity and by
histologic evaluation. Hepes-buffered
Hanks' balanced salt solution (HHBSS) is
effective as a tissue culture medium (mini-
mum essential medium) in maintaining
glucose utilization, but phosphate-buffered
saline solution results in the loss ofglucose
metabolism within 12 hr (Figure 1). The
simplified formulation of a balanced salt
solution may be advantageous during
analysis of receptor fluid contents after an
absorption and metabolism study. For this
reason, we routinely used HHBSS as the
receptor fluid in our studies.
Absorption andMetabolism Data
The influence of metabolism on percuta-
neous absorption has been examined in dif-
fusion cells by using model compounds
with different metabolic pathways.
Metabolism by P450 enzymes in skin
during absorption was assessed in studies
with four readily absorbed compounds: 7-
ethoxycoumarin (10), benzo[a]pyrene
(10), testosterone (9), and estradiol (9).
The metabolism of7-ethoxycoumarin to 7-
hydroxycoumarin was small in humans and
several species of rodents (Figure 2). Only
0.1% ofthe absorbed dose was metabolized
in human skin, whereas 1.2% was metabo-
lized with skin from the Sencar mouse.
Benzo[a]pyrene is metabolized to
numerous compounds in skin and other
organs. Metabolites formed in rodent skin
were quantitated by thin-layer chromatog-
raphy and identified by comparison with
lable 4. Metabolism of radioactive testosterone simultaneously administered intravenously(14C) and percutaneously
H) in humans.
5a/5,B ratio of androstanediols 5a/5, ratio of 17-ketosteroids
Male subject Intravenous Percutaneous Intravenous Percutaneous
JM 0.5 1.6 0.9 1.2
FC 0.4 1.2 0.9 1.7
AH 0.6 2.4 0.8 1.3
PM 0.5 1.3 1.0 1.1
Average 0.5 1.6 0.9 1.3
Values were determined from urine samples collected for a 3-day period. Modified from Mauvais-Jarvis et al. (7).
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Figure 1. Rates of anaerobic glucose utilization of skin sections perfused over a 24-
hr period. Skin sections from fuzzy rats were pefused in flow-through diffusion cells
with Eagle's minimal essential medium, HEPES-buffered Hanks' balanced salt solu-
tion, Dulbecco's modified phosphate-buffered saline, or phosphate-buffered saline
with 0.1% (w/v) glucose. Results are expressed as means ± SEM.
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Figure 3. Percentage of absorbed benzo[a]pyrene metabolized by (A) hairless guinea
pig and (B) Sencar mouse skin in 24 hr in flow-through diffusion cell. Values are means
± SEM offour orfive determinations.
H FuzsyRat
M Hairless guinlea, pig
_ Htirman
m. Sencar mouLse
= Ralb/c mouse
2.0
80 T
CL03,
Figure 2. (A) Percentage of applied 7-ethoxycoumarin (7-EC) absorbed in 24 hr. (B) Percentage of absorbed 7-
ethoxycoumarin metabolized in 24 hr by skin in flow-through diffusion cells. Values from two to four skin samples
from each experimental subject were averaged and constitute one experiment. Values are means ± SEM of two or
three experiments. Rat, guinea pig, and human skin were 200-pm sections; mouse skin was full thickness.
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Figure 4. Percentage of applied compound absorbed
and percentage of absorbed compound metabolized for
benzoic acid and derivatives. Experiments were con-
ducted for48 hrwith unabsorbed material washed from
the surface of the skin at 24 hr. PABA, p-aminobenzoic
acid.
standards. The aqueous fraction probably
contains polar conjugates of benzo[a]-
pyrene that cannot be extracted into ethyl
acetate. When total metabolism is
expressed in terms ofthe absorbed dose, we
obtained about 4% (hairless guinea pig)
and 8% (Sencar mouse) (Figure 3).
Testosterone and estradiol were more
completely metabolized than the previous
two compounds during skin permeation in
the rat (9). Approximately 20% of the
absorbed estradiol was converted to
estrone. Testosterone metabolites totaled
more than 30% of the absorbed material
and cochromatographed with standards for
5x-androstane-3,17-diol; 4-androstane-
3,17-dione; and 5a-dihydrotestosterone.
Additional biotransformation reactions
were observed in hairless guinea pig skin
with benzoic acid, p-aminobenzoic acid
(PABA), and benzocaine (Figure 4) (11). A
small amount of absorbed benzoic acid
(approximately 7%) was converted to the
glycine conjugate ofbenzoic acid (hippuric
acid) during percutaneous absorption.
Acetylation ofprimary amino groups can
occur extensively in skin. PABA and ben-
zocaine were substantially converted to the
acetylated metabolite during absorption.
Benzocaine was also a substrate for esterase,
but because the conversion of benzocaine
to PABA was small, it is a poor substrate
for this enzyme. Metabolism ofbenzocaine
was similar in human and hairless guinea
pig skin.
The absorption and metabolism ofben-
zocaine were examined in the hairless
guinea pig after application in awater-solu-
ble gel (12). A radiotracer dose (2 pg/cm )
was compared with a 20-fold larger dose
used to approximate concentrations ofben-
zocaine applied for topical anesthesia. At
the low dose, 80% ofabsorbed benzocaine
was metabolized to N-acetylbenzocaine. At
the high dose, saturation of skin acetyl-
transferase limited N-acetylbenzocaine for-
mation, but 47% of the absorbed
benzocaine was acetylated.
In preliminary studies, azo colors were
observed to undergo azo reduction during
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skin absorption (13). Several azo com-
pounds that are simple derivatives of ani-
line were synthesized and found to be
metabolized to aniline during azo reduc-
tion. The aniline was further biotrans-
formed to other compounds with the
N-acetylated derivative acetanilide as the
most predominate.
PBPKModel-Dennal Input
A PBPK model is being developed for pre-
dicting in vivo blood and tissue concentra-
tions of a chemical after topical exposure
(14). In vitro skin absorption and metabo-
lism of benzoic acid were measured with
viable hairless guinea pig skin in a diffusion
cell and described mathematically for input
into the PBPK model. Tissue-plasma parti-
tion coefficients and Michaelis-Menton
metabolic constants (Km, Vax) were deter-
mined by in vitro techniques. Predicted
blood levels after three different topical
doses ofbenzoic acid agreed closely with in
vivo measurements. A PBPK model may be
useful for determining the influence of
metabolism at the absorption site on the
systemic effects ofa toxicant.
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